| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Officer | Chf Scientific Operations Officer | Sr. Vice President, Research
1 company
Zummo Jacqueline is a Chief R&D Officer at TARA. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $512K at current prices.
Zummo Jacqueline's largest disclosed position is in TARA as Chief R&D Officer, worth about $512K. The recent filings there lean toward selling, a net 44,956 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | TARA Protara Therapeutics, Inc. | Chief R&D Officer | Sell | 1,134 | $5.40 | $6,123.60 | -1.2% | -18.2% | - | |
| Apr 1, 2026 | TARA Protara Therapeutics, Inc. | Chief R&D Officer | Sell | 22,598 | $5.26 | $118,865.48 | -19.1% | -24.2% | - | |
| Mar 26, 2025 | TARA Protara Therapeutics, Inc. | Chf Scientific Operations Officer | Sell10b5-1 | 21,224 | $4.53 | $96,144.72 | -17.7% | -32.5% | +14.6% |